TELA Bio Net Income 2024

TELA Bio Net Income

-43.82 M USD

TELA Bio Dividend yield

Ticker

TELA

ISIN

US8723811084

WKN

A2PUP9

In 2024, TELA Bio's profit amounted to -43.82 M USD, a -6.1% increase from the -46.66 M USD profit recorded in the previous year.

The TELA Bio Net Income history

YEARNET INCOME (undefined USD)
2028e41.23
2027e11.06
2026e-19.44
2025e-31.35
2024e-43.82
2023-46.66
2022-44.3
2021-33.28
2020-28.79
2019-30.21
2018-29.92
2017-27.23

TELA Bio Aktienanalyse

What does TELA Bio do?

TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding TELA Bio's Profit Margins

The profit margins of TELA Bio represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of TELA Bio's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating TELA Bio's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

TELA Bio's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When TELA Bio’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about TELA Bio Stock

How much profit has TELA Bio made this year?

TELA Bio has made -43.82 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -6.1% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does TELA Bio publish its earnings?

TELA Bio publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of TELA Bio?

The profits of TELA Bio are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of TELA Bio?

You can learn more about the earnings of TELA Bio by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does TELA Bio pay?

Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.

What is the dividend yield of TELA Bio?

The current dividend yield of TELA Bio is .

When does TELA Bio pay dividends?

TELA Bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TELA Bio?

TELA Bio paid dividends every year for the past 0 years.

What is the dividend of TELA Bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TELA Bio located?

TELA Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TELA Bio from 5/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.

When did TELA Bio pay the last dividend?

The last dividend was paid out on 5/8/2024.

What was the dividend of TELA Bio in the year 2023?

In the year 2023, TELA Bio distributed 0 USD as dividends.

In which currency does TELA Bio pay out the dividend?

The dividends of TELA Bio are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TELA Bio

Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.